Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.

REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).

Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.

The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...

New data from Spherix Global Insights uncover how hematologists are defining the “right patient” for gene therapy, balancing promise with practical barriers in sickle cell disease, thalassemia, and ...

You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical ...

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive ...

You can always be judged by your scars. This is the idea that sums up one of the new breakthroughs in basic and biomedical research published today in ...

Is kidney xenotransplantation an answer to the kidney organ shortage? Experts weigh in the current promise and potential medical hurdles.

CRISPR therapies offer precise gene-editing solutions for treating genetic disorders and other complex diseases. Rising prevalence of genetic conditions drives adoption, and emerging CRISPR-based ...

Panelists discuss how bimekizumab treatment preserves workforce participation and productivity while maintaining a favorable safety profile. Oral candidiasis is the main distinguishing side effect ...

Cardiologist Dr. Dmitry Yaranov, widely known as @heart_transplant_doc, has outlined what he calls the “crazy future of heart ...